Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)
China flag China · Delayed Price · Currency is CNY
17.07
-0.06 (-0.35%)
May 8, 2026, 3:00 PM CST

SHA:601607 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
287,052282,552274,187259,152231,240215,824
Other Revenue
1,0271,0271,0641,143741.24-
288,079283,580275,251260,295231,981215,824
Revenue Growth (YoY)
4.43%3.03%5.75%12.21%7.49%12.46%
Cost of Revenue
256,870253,207244,837229,366201,604187,416
Gross Profit
31,20930,37330,41330,92930,37728,408
Selling, General & Admin
18,96318,45818,32619,52719,17318,376
Research & Development
2,3112,3402,3942,2042,1121,987
Other Operating Expenses
633.12640.28143.51376.86654.72633.18
Operating Expenses
22,39821,91021,09622,34922,21420,942
Operating Income
8,8118,4639,3178,5818,1647,466
Interest Expense
-1,589-1,686-1,857-1,885-1,689-1,518
Interest & Investment Income
3,3593,575902.81461.83971.412,150
Currency Exchange Gain (Loss)
-62.04-62.04-73.9311.4121.5110.1
Other Non Operating Income (Expenses)
-208.11-168.04-166.21-109.59-116.44-128.71
EBT Excluding Unusual Items
10,31010,1228,1237,0597,3517,979
Impairment of Goodwill
-328.53-328.53-230.47---19.21
Gain (Loss) on Sale of Investments
341.61332.12178.43155.93218.74-206
Gain (Loss) on Sale of Assets
326.85157.15187.9792.481,43958.29
Asset Writedown
-813.52-707.97-218.05-70.65-322.79-69.77
Legal Settlements
-46.79-46.79-26.56-12.69-37.38-8.1
Other Unusual Items
296.89292.175.56-169.95160.13409.61
Pretax Income
10,0869,8208,0207,0548,8088,144
Income Tax Expense
2,9032,8462,1501,8881,8161,869
Earnings From Continuing Operations
7,1846,9745,8705,1676,9926,275
Minority Interest in Earnings
-1,374-1,249-1,317-1,399-1,375-1,181
Net Income
5,8095,7254,5533,7685,6175,093
Net Income to Common
5,8095,7254,5533,7685,6175,093
Net Income Growth
33.75%25.75%20.82%-32.92%10.28%13.28%
Shares Outstanding (Basic)
3,7083,7083,7043,7013,4832,842
Shares Outstanding (Diluted)
3,7083,7083,7043,7013,4832,842
Shares Change (YoY)
-0.13%0.11%0.07%6.28%22.54%-
EPS (Basic)
1.571.541.231.021.611.79
EPS (Diluted)
1.561.541.231.021.611.79
EPS Growth
33.60%25.30%20.73%-36.77%-10.06%13.29%
Free Cash Flow
5,0663,8283,4262,2612,058942.55
Free Cash Flow Per Share
1.371.030.930.610.590.33
Dividend Per Share
0.4700.4700.3700.4100.6100.420
Dividend Growth
27.03%27.03%-9.76%-32.79%45.24%-12.50%
Gross Margin
10.83%10.71%11.05%11.88%13.10%13.16%
Operating Margin
3.06%2.98%3.38%3.30%3.52%3.46%
Profit Margin
2.02%2.02%1.65%1.45%2.42%2.36%
Free Cash Flow Margin
1.76%1.35%1.24%0.87%0.89%0.44%
EBITDA
10,87410,45211,01510,0819,6898,973
EBITDA Margin
3.77%3.69%4.00%3.87%4.18%4.16%
D&A For EBITDA
2,0631,9901,6981,5001,5261,507
EBIT
8,8118,4639,3178,5818,1647,466
EBIT Margin
3.06%2.98%3.38%3.30%3.52%3.46%
Effective Tax Rate
28.78%28.98%26.81%26.76%20.62%22.95%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.